CIK 0001069899 · Large accelerated filer
PHIBRO ANIMAL HEALTH CORP
Sign in to watch- Ticker
- PAHC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 131840497
- Phone
- 201-329-7300
- Business address
- GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
- Former names
- PHILIPP BROTHERS CHEMICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-23 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −590 | $32.18 | $19K | 0 |
| 2019-01-23 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −2,500 | 12,280 | ||
| 2019-01-22 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +2,500 | $11.83 | $30K | 2,500 |
| 2019-01-22 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −2,500 | $31.40 | $79K | 0 |
| 2019-01-22 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −2,500 | 14,780 | ||
| 2019-01-18 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +2,500 | $11.83 | $30K | 2,500 |
| 2019-01-18 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −2,500 | $32.04 | $80K | 0 |
| 2019-01-18 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −2,500 | 17,280 | ||
| 2019-01-17 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +2,500 | $11.83 | $30K | 2,500 |
| 2019-01-17 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −2,500 | $32.24 | $81K | 0 |
| 2019-01-17 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −2,390 | 0 | ||
| 2019-01-17 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −110 | 19,780 | ||
| 2019-01-16 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +2,500 | $11.83 | $30K | 2,500 |
| 2019-01-16 | Bendheim Daniel M Exec. VP, Corporate Strategy | Sale | −2,500 | $32.40 | $81K | 0 |
| 2019-01-16 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise · Option to purchase Common Stock | −2,500 | 2,390 | ||
| 2019-01-15 | Warras Dean J Pres Animal Health & Nutr N.A. | Option exercise | +21,560 | $11.83 | $255K | 21,560 |
| 2019-01-15 | Warras Dean J Pres Animal Health & Nutr N.A. | Sale | −21,560 | $31.81 | $686K | 0 |
| 2019-01-15 | Warras Dean J Pres Animal Health & Nutr N.A. | Option exercise · Option to purchase Class A Common Stock | −1,670 | 0 | ||
| 2019-01-15 | Warras Dean J Pres Animal Health & Nutr N.A. | Option exercise · Option to purchase Class A Common Stock | −19,890 | 0 | ||
| 2019-01-09 | Bendheim Daniel M Exec. VP, Corporate Strategy | Option exercise | +2,500 | $11.83 | $30K | 2,500 |
Page 11 of 18 · 343 trades